Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
Ferjancic Z, Bihelovic F, Vulovic B, Matovic R, Trmcic M, Jankovic A, Pavlovic M, Djurkovic F, Prodanovic R, Djurdjevic Djelmas A, Kalicanin N, Zlatovic M, Sladic D, Vallet T, Vignuzzi M, Saicic RN.
Ferjancic Z, et al. Among authors: jankovic a.
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2289007. doi: 10.1080/14756366.2023.2289007. Epub 2023 Dec 12.
J Enzyme Inhib Med Chem. 2024.
PMID: 38086763
Free article.